Vion, University of Innsbruck, Austria Wirtschaftsservice GmbH deal

VION exercised an option under a 2003 deal to exclusively license preclinical heterocyclic hydrazone compounds to treat cancer from inventors at the university and from Austria Wirtschaftsservice, a t...